Nanjing Hairun Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Jiangsu Aosaikang Pharmaceutical Co., Ltd., located at No. 39 Guanchunan Road, Nanjing Chemical Industry Park, and was established on August 15, 2013. It covers an area of 58 mu, with Phase I occupying 30 mu and a building area of 20,000 square meters, with a total investment of 140 million yuan. Phase II covers 28 mu and is planned to commence construction in 2021. Hairun Pharmaceutical produces conventional active pharmaceutical ingredients (APIs) and anti-tumor APIs, mainly dedicated to the production of drugs in four major fields: anti-gastrointestinal ulcer, anti-tumor, diabetes, and deep infection, while also undertaking the task of transforming new products from the research institute. Hairun Pharmaceutical has always taken routine GMP management as its core, adopting a manufacturing system based on a three-level quality management system and refined management, and all production lines in the current plant have passed the new version of GMP certification. The company's APIs have accelerated their pace of internationalization, and new development momentum is gathering; in the future, they will be exported to countries such as Europe and the United States.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows